Anti-Parkinson Drugs

All categories
DBCAT002254Therapeutic categoryN04

Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. A DrugBank category of 49 drugs. 30 of them are approved.

ATC classification
Also known as
Agents, Antiparkinson · Agents, Antiparkinsonian · Anti-Parkinson's Agents · Antiparkinson Agents · Antiparkinson Drugs
Drugs

and 24 more with a free account

What you can answer from here — as of August 12, 2019

49DrugsEach linked to its full drug card
Sign in
70Drug targetsEvery drug–target pair in the class, with bond type
Sign in
8,943Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
13Routes of administrationHow the drugs in this class are given
Sign in
1SubcategoryNarrower classes within this one
Sign in

Which targets do Anti-Parkinson Drugs share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In